Northcoast Research analyst Ryan Connors downgrades Franklin Electric (NASDAQ:FELE) from Buy to Neutral.
Bristol Myers Squibb Receives Positive CHMP Opinion For CAR T Cell Therapy Breyanzi For Relapsed Or Refractory DLBCL, PMBCL And FL3B
Bristol Myers Squibb (NYSE:BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi (lisocabtagene